Inflammatory mediators in atherosclerotic vascular disease

Basic Research in Cardiology

Volumn 100, Issue 2, 2005, Pages 93-101

  Zernecke, Alma ^a   Weber, Christian ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Atherosclerosis; Chemokines; Cytokines; Inflammation

Indexed keywords

ALPHA CHEMOKINE; APOLIPOPROTEIN E; BETA CHEMOKINE; CD40 LIGAND; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR2; CXCL9 CHEMOKINE; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN PARC; RANTES; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNINDEXED DRUG;

ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL INFILTRATION; CELL INTERACTION; CELL SUBPOPULATION; DISEASE COURSE; EDITORIAL; GENE DELETION; HYPERLIPIDEMIA; IN VITRO STUDY; INNATE IMMUNITY; MONONUCLEAR CELL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; VASCULAR LESION;

ANIMALS; ATHEROSCLEROSIS; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOKINE CX3CL1; CHEMOKINE CXCL12; CHEMOKINES, CC; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, CCR2; STEM CELLS;

EID: 14944378649     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-005-0511-6     Document Type: Editorial

References (97)

1. Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD (2000) The stromalcell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 86:131-138
2. + CXC chemokine-induced angiogenic activity. J Immunol 165:5269-5277
3. 3C motif. Nature 385:640-644 10.1038/385640a0
4. Blake GJ, Ridker PM (2001) Novel clinical markers of vascular wall inflammation. Circ Res 89:763-771
5. Bobryshev YV, Lord RS (1998) Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res 37:799-810
6. Boisvert WA, Santiago R, Curtiss LK,Terkeltraub RA (1998) A leukocyte homologue of the IL-8 receptor CXCR-2mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 101:353-363
7. Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atheroslerosis. Nature 3954:894-897
8. Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S (2004) Inhibition of Tumor Necrosis Factor-{alpha} Reduces Atherosclerosis in Apolipoprotein E Knockout Mice. Arterioscler Thromb Vasc Biol. Epub ahead of print
9. Burger-Kentischer A, Goebel H, Seiler R,Fraedrich G, Schaefer HE, Dimmeler S, Kleemann R, Bernhagen J, Ihling C (2002) Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 105:1561-1566
10. Chen Z, Sakuma M, Zago AC, Zhang X, Shi C, Leng L, Mizue Y, Bucala R, Simon DI (2004) Evidence for a role of macrophage migration inhibitory factor in vascular disease. Arterioscler Thromb Vasc Biol 4:709-714
11. Chuntharapai A, Lee J, Hebert CA, Kim KJ (1994) Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 153:5682-5688
12. Cinamon G, Shinder V, Alon R (2001) Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat Immunol 2:515-522
13. Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Baggioloni M, Wells TN (2000) Functional expression of CCR1, CCR3, CCR4 and CXCR4 chemokine receptors on human platelets. Blood 96:4046-4054
14. Combadiere C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, Debre P,Tedgui A, Murphy PM, Mallat Z (2003) Decreased atherosclerotic lesion formation in CXCR1/apolipoprotein E double knockout mice. Circulation 107:1009-1016
15. Damas JK, Waehre T, Yndestadt A, Ueland T, Muller F, Eiken HG, Holm AM, Halvorsen B, Froland SS, Gullestad L, Aukrust P (2002) Stromal cell-derivedfactor-1α in unstable angina: Potential antiinflammatory and matrix-stabilizing effects. Circulation 106:36-42
16. Dawson TC, Kuziel WA, Osahar TA, Maeda N (1999) Abesence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143:205-211
17. Egashira K, Zhao Q, Kataoka C, Ohtani K, Usui M, Charo IF, Nishida K, Inoue S, Katoh M, Ichiki T, Takeshita A (2002) Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res 90:1167-1172
18. Elhage R, Maret A, Pieraggi MT, Thiers JC, Arnal JF, Bayard F (1998) Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation 97:242-244
19. Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T, Patel DD (1998) Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and acitivation under physiologic flow. J Exp Med 188:1413-1419 10.1084/jem.188.8.1413
20. Furukawa Y, Matsumori A, Ohashi N, Shioi T, Ono K, Harada A, Matsushima K, Sasayama S (1999) Anti-monocyte chemoattractant proetin-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ Res 84:306-314
21. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW (2001) Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276:37993-38001
22. George JN, Onofre AR (1982) Human platelet surface binding of endogenous secreted factor VIII-von Willebrand factor and platelet factor 4. Blood 59:194-197
23. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr,Luster AD, Luscinskas FW, Rosenzweig A (1999) MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718-723
24. Greaves DR, Häkkinen T, Lucas AD, Liddiard K, Jones E, Quinn CM, Senaratne J, Green FR, Tyson K, Boyle J, Shanahan C, Weissberg PL, Gordon S, Ylä-Hertualla S (2001) Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- andactivation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21:923-929
25. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2:275-281 10.1016/S1097-2765(00)80139-2
26. Guo J, Van Eck M, Twisk J, Maeda N, Benson GM, Groot PH, Van Berkel TJ (2003) Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis. Arterioscler Thromb Vasc Biol 23:447-453
27. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C (1997) IFN-gamma potentiates atherosclerosis in Apo Eknock-out mice. J Clin Invest 99:2752-2761
28. Haley KJ, Lilly CM, Yang JH, Feng Y, Kennedy SP, Turi TG, Thompson JF, Sukhova GH, Libby P, Lee RT (2000) Over expression of eotaxin and the CCR3 receptor in human atherosclerosis: Using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 102:2185-2189
29. Han CI, Campbell GR, Campbell JH (2001) Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 38:113-119
30. Han KH, Tangirala RK, Green SR, Quehenberger O (1998) Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler Thromb Vasc Biol 18:1983-1991
31. Hansson GK (2001) Immune mechanismsin atherosclerosis. Arterioscler Thromb Vasc Biol 21:1876-1990
32. Hansson GK, Libby P, Schonbeck U, Yan ZQ (2002) Innate and adaptive immunityin the pathogenesis of atherosclerosis. Circ Res 91:281-291
33. Haque N, Zhang X, French D, Li J, Poon M, Fallon JT, Gabel B, Taubmann MB, Koschinsky M, Harpel PC (2000) CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation 102:786-792
34. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594
35. Horvath C, Welt FG, Nedelmann M, Rao P, Rogers C (2002) Targeting CCR2 or CD18 inhibits experimental in-stentrestenosis in primates: Inhibitory potential depends on type of injury and leukocytes targed. Circ Res 90:488-494
36. Huo Y, Schober A, Forlow B, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nature Medicine 9:61-67
37. Huo Y, Weber C, Forlow SB, Sperandio M, Thatte J, Mack M, Jung S, Littman DR, Ley K (2001) The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest 108:1307-1314
38. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1781 1:CAS:528:DyaK3sXlslyktg%3D%3D
39. Kuschert GS, Coulin F, Power CA, Proudfoot AE, Hubbard RE, Hoogewerf AJ, Wells TN (1999) Glycosaminoglycans interact selectively with chemokines andmodulate receptor binding and cellular responses. Biochemestry 38:12959-12968
40. Kuziel WA, Dawson TC, Quinones M, Garavito E, Chenaux G, Ahuja SS, Reddick RL, Maeda N (2003) CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis 167:25-32
41. Lapidot T, Petit I (2002) Current understanding of stem cell mobilization: Theroles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 30:973-981 10.1016/ S0301-472X(02)00883-4
42. 3CR1-/-mice reveals a role for fractalkine in atherogenesis (2003) J Clin Invest 111:333-340 10.1172/JCI200315555
43. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874 10.1038/nature01323
44. Liehn EA, Schober A, Weber C (2004) Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 24:1891-1896
45. Lin SG, Yu XY, Chen YX, Huang XR, Metz C, Bucala R, Lau CP, Lau HY (2000) Denovo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res 87:1202-1208
46. Lucas AD, Bursill C, Guzik TJ, Sadowski J, Channon KM, Greaves DR (2003) Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation 108:2498-2504
47. Lundahl J, Skold CM, Hallden G, Hallgren M, Eklund A (1996) Monocyte and neutrophil adhesion to matrix proteins is selectively enhanced in the presence of inflammatory mediators. Scand J Immunol 44:143-149
48. Lutgens E, Gorelik L, Daemen MJ, deMuinck ED, Grewal IS, Koteliansky VE, Flavell RA (1999) Requirement for CD154 in the progression of atherosclerosis. Nat Med 5:1313-1316
49. Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, Libby P, Luster AD (1999) Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 104:1041-1050
50. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394:200-203
51. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A (1999) Protective role of interleukin-10 inatherosclerosis. Circ Res 85:17-24
52. Minami M, Kume N, Shimaoka T, Kataoka H, Hayashida K, Akiyama Y, Nagata I, Ando K, Nobuyoshi M, Hanyuu M, Komeda M, Yonehara S, Kita T (2001) Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21:1796-1800
53. Mori E, Komori K, Yamaoka T, Tanii M, Kataoka C, Takeshita A, Usui M, Egashira K, Sugimachi K (2002) Essential role of monocyte chemoattractant protein-1 indevelopment of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits. Circulation 105:2905-2910
54. Moser B, Barella L, Mattei S, Schumacher C, Boulay F, Colombo MP, Baggiolini M(1993) Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem J 294:285-292
55. Namiki M, Kawashima S, Yamashita T, Ozaki M, Hirase T, Ishida T, Inoue N, Hirata K, Matsukawa A, Morishita R,Kaneda Y, Yokoyama M (2002) Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces inflitration of macrophages and formation of atherosclerotic lesion: Synergism with hypercholesterolemia. Arterioscler Thromb Vasc Biol 22:115-120
56. Nelken NA, Coughlin SR, Gordon D, Wilcox JN (1991) Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88:1121-1127 1:CAS:528:DyaK3MXmsFeitL4%3D
57. Ni W, Egashira K, Kitamoto S, Kataoka C, Koyanagi M, Inoue S, Imaizumi K, Akiyama C, Nishida KI, Takeshita A (2001) New anti-monocyte chemoattractant protein-1 gene therapy attenuates athersclerosis in apolipoprotein Eknockout Mice. Circulation 103:2096-2101
58. Pan JH, Sukhova GK, Yang JT, Wang B, Xie T, Fu H, Zhang Y, Satoskar AR, David JR, Metz CN, Bucala R, Fang K, Simon DI, Chapman HA, Libby P, Shi GP (2004) Macrophage migration inhibitory factor deficiency impairs atherosclerosis in lowdensity lipoprotein receptor-deficient mice. Circulation 109:3149-4153
59. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, Ben-Hur H, Many A, Shultz L, Lider O, Alon R, Zipori D, Lapidot T (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283:845-848
60. Piali L, Weber C, LaRosa G, Mackay CR, Springer TA, Clark-Lewis J, Moser B (1998) The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur J. Immunol 28:961-972
61. Ponomaryov T, Peled A, Petit I, Taichman RS, Habler L, Sandbank J, Arenzana-Seisdedos F, Magerus A, Caruz A, Fujii N,Nagler A, Lahav M, Szyper-Kravitz M, Zipori D, Lapidot T (2000) Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 106:1331-1339
62. Poole JC, Florey HW (1958) Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits. J Pathol Bacteriol 75:245-251
63. Reape TJ, Groot PH (1999) Chemokines and atherosclerosis. Atherosclerosis 147:213-225 10.1016/S0021-9150(99)00346-9
64. Reape TJ, Rayner K, Manning CD, Gee AN, Barnette MS, Burnand KG, Groot PH (1999) Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am J Pathol 154:365-374
65. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK (2003) Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 112:1342-1350
66. Roque M, Kim WJ, Gazdoin M, Malik A, Reis ED, Fallon JT, Badimo JJ, Charo IF, Taubman MB (2002) CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol 22:554-559
67. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R (2002) Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8:403-409 10.1038/nm0402-403
68. Schäfer A, Schulz C, Eigenthaler M, Fraccarollo D, Kobsar A, Gawaz M, Ertl G,Walter U, Bauersachs J (2003) Novel role of the membrane bound chemokine fractalkine in platelet activation and adhesion. Blood 103:407-412
69. Schober A, Bernhagen J, Thiele M, Zeiffer U, Knarren S, Roller M, Bucala R, Weber C (2004) Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 109:380-385
70. Schober A, Knarren S, Lietz M, Lin E, Weber C (2003) Crucial role of stromalcell-derived factor-1a in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 108:2491-2497
71. Schober A, Manka D, von Hundelshausen P, Huo Y, Hanrath P, Sarembock IJ, Ley K, Weber C (2002) Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 106:1523-2529
72. Schober A, Zernecke A, Liehn EA, von Hundelshausen P, Knarren S, Kuziel WA, Weber C. CCR2 (2004) The crucial role of the CCL2/CXCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocytes recruitment and CCL2 presentation on platelets. Circ Res 95:1125-1133
73. Schreyer SA, Peschon JJ, LeBoeuf RC (1996) Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem 271:26174-26178
74. Schreyer SA, Vick CM, LeBoeuf RC (2002) Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J Biol Chem 277:12364-12368
75. Schwartz D, Andalibi A, Chaverri-Almada L, Berliner JA, Kirchgessner T, Fang ZT, Tekamp-Olson P, Lusis AJ, Gallegos C, Fogelman AM et al. (1994) Role of GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. J Clin Invest 94:1968-1973
76. Sheikine Y, Hansson G (2004) Chemokines and atherosclerosis. Ann Med 36:98-118 10.1080/07853890310019961
77. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM (2002) Smooth muscle progenitor cells in human blood. Circulation 106:1199-1204
78. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301-314 10.1016/ 0092-8674(94)90337-9
79. Steinberg D (2002) Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nat Med 8:1211-1217
80. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nischikawa S, Kishimoto T, Nagasawa T (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestenial tract. Nature 393:591-594
81. Taubmann MB, Rollins BJ, Poon M, Marmur J, Green RS, Berk BC, Nadal-Ginard B (1992) JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res 70:314-325
82. Tellides G, Tereb DA, Kirkiles-Smith NC, Kim RW, Wilson JH, Schechner JS, Lorber MI, Pober JS (2000) Interferongamma elicits arteriosclerosis in the absence of leukocytes. Nature 403:207-211
83. Tsou CL, Haskell CA, Charo LF (2001)Tumor necrosis factor-α-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem 276:44622-44626
84. Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F (2004) Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res 94:253-261
85. Veillard NR, Steffens S, Burger F, Pelli G, Mach F (2004) Differential Expression Patterns of Proinflammatory and Antiin-flammatory Mediators During Atherogenesis in Mice. Arterioscler Thromb Vasc Biol 24:2339-2344
86. Veillard NR, Lu B, Pelli G, Kwak B, Charo I, Grerard C, Mach F (2003) Crucial role for both chemokines receptors CCR2 and CXCR3 in atherogenesis. Eur Heart J 24:A337
87. von Hundelshausen P, Weber KSC, Huo Y, Proudfoot AEI, Nelson PJ, Ley K, Weber C (2001) RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103:1772-1777
88. Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A (1996) Interleukin-8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem 271:8837-8842
89. Weber C (2003) Novel mechanistic concepts for the control of leukocyte transmigration; specialization of integrins, chemokines and junctional molecules. J Mol Med 81:4-19
90. Weber C, Schober A, Zernecke A (2004) Chemokines. Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease. Arterioscler Thromb Vasc Biol 24:1997-2008
91. Weber C, Weber KSC, Klier C, Gu H, Horuk R, Wank R, Nelson PJ (2001) Specialized roles of the chemokine receptors CCR1 and CCR5 in recruitment of monocytes and Th1-like/CD45RO+T cells. Blood 97:1144-1146
92. Weber KSC, von Hundelshausen P, Weber PC, Clark-Lewis I, Weber C (1999) Differential chemokine immobilization and hierarchical involvement of their receptors in monocyte arrest and transmigration on inflammatory endothelium. Eur J Immunol 29:700-712
93. Wilcox JN, Nelken NA, Coughlin SR, Gordon D, Schall TJ (1994) Local expression of inflammatory cytokines in human atherosclerotic plaques. J Atheroscler Thromb 1:S10-13
94. Wuttge DM, Zhou X, Sheikine Y, Wagsater D, Stemme V, Hedin U, Stemme S, Hansson GK, Sirsjo A (2004) CXCL16/SR-PSOX is an interferon-γ-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 24:750-755
95. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Goldberg IJ, Steinberg D, Witztum JL (1991) Expression of monocyte chemoattractant protein-1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88:5252-5256
96. Yu X, Dluz S, Graves DT, Zhang L, Antoniades HN, Hollander W, Prusty S, Valente AJ, Schwartz CJ, Sonenshein GE (1992) Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acid Sci USA 89:6953-6957
97. Zernecke A, Weber KS, Erwig LP, Kluth DC, Schröppel D, Rees AJ, Weber C (2001) Combinatorial model of chemokine involvement in glomerular monocyte recruitment: Role of CXCR2 in infiltration during nephrotoxic. J Immunol 166:5755-5762